NO20071244L - Anvendelse av cellespesifikke konjugater for behandling av inflammasjonssykdommer i gastrointestinaltrakten - Google Patents

Anvendelse av cellespesifikke konjugater for behandling av inflammasjonssykdommer i gastrointestinaltrakten

Info

Publication number
NO20071244L
NO20071244L NO20071244A NO20071244A NO20071244L NO 20071244 L NO20071244 L NO 20071244L NO 20071244 A NO20071244 A NO 20071244A NO 20071244 A NO20071244 A NO 20071244A NO 20071244 L NO20071244 L NO 20071244L
Authority
NO
Norway
Prior art keywords
inflammatory
gastrointestinal tract
treatment
inflammatory diseases
cell
Prior art date
Application number
NO20071244A
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Linda Tomaskovic
Stribor Markovic
Original Assignee
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb
Publication of NO20071244L publication Critical patent/NO20071244L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår fremgangsmåter for å hindre eller behandle inflammatoriske sykdommer, forstyrrelser og tilstander i den gastrointestinale trakten ved å administrere til en pasient som trenger slik behandling konjugatforbindelser med formel (VII) som har lav oral biotilgjengelighet eller farmasøytisk akseptable salter, prodrug eller solvater derav. M representerer en makrolidunderenhet som fremviser egenskapene med akkumulering i inflammasjonsceller, T representerer en antiinflammasjonsunderenhet som kan være et steroid eller ikke-steroid (ikke-stereoidal bestanddel) avledet fra et ikke-steroid legemiddel med antiinflammatorisk, analgesi og/eller antipiretisk aktivitet (NSAID) og/eller representerer en bindingsgruppe som kovalent binder M og T. Foreliggende beskrivelse angår også farmasøytiske sammensetninger som inneholder konjugatforbindelser med formel (VII) som har lav oral biotilgjengelighet.
NO20071244A 2004-08-12 2007-03-07 Anvendelse av cellespesifikke konjugater for behandling av inflammasjonssykdommer i gastrointestinaltrakten NO20071244L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60108704P 2004-08-12 2004-08-12
US60331504P 2004-08-19 2004-08-19
PCT/IB2005/002406 WO2006018698A2 (en) 2004-08-12 2005-08-10 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract

Publications (1)

Publication Number Publication Date
NO20071244L true NO20071244L (no) 2007-04-17

Family

ID=35602235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071244A NO20071244L (no) 2004-08-12 2007-03-07 Anvendelse av cellespesifikke konjugater for behandling av inflammasjonssykdommer i gastrointestinaltrakten

Country Status (13)

Country Link
US (1) US20060035845A1 (no)
EP (1) EP1778292A2 (no)
JP (1) JP2008509899A (no)
KR (1) KR20070046917A (no)
AU (1) AU2005273592A1 (no)
BR (1) BRPI0514254A (no)
CA (1) CA2576291A1 (no)
IL (1) IL181240A0 (no)
MA (1) MA28809B1 (no)
MX (1) MX2007001669A (no)
NO (1) NO20071244L (no)
RU (1) RU2007108544A (no)
WO (1) WO2006018698A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8282678B2 (en) 2002-11-13 2012-10-09 Allium Medical Solutions Ltd. Endoluminal lining
MX2007005073A (es) * 2004-10-27 2007-06-25 Glaxosmithkline Zagreb Conjugados con actividad antiinflamtoria.
US8133268B2 (en) 2007-05-30 2012-03-13 Cordis Corporation Stent/fiber structural combinations
WO2010045180A1 (en) 2008-10-13 2010-04-22 Metabolon, Inc. Biomarkers for inflammatory bowel disease and methods using the same
ES2633737T3 (es) * 2010-05-25 2017-09-25 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Levocarrimicina, composiciones farmacéuticas, procedimientos de preparación y utilizaciones de la misma
EP2578595B1 (en) * 2010-05-25 2017-04-19 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Crystalline levoisovalerylspiramycin i
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
WO2024117797A1 (ko) * 2022-11-29 2024-06-06 제일약품 주식회사 자스타프라잔 또는 이의 약제학적으로 허용되는 염을 포함하는 약제 연관 소화성 궤양의 예방 또는 치료용 약학적 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPH07103148B2 (ja) * 1991-12-16 1995-11-08 株式会社ディ・ディ・エス研究所 アントラサイクリン−マクロライド複合体
HRP20010018A2 (en) * 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US20040186063A1 (en) * 2002-02-15 2004-09-23 Hans-Jurgen Gutke Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2003070174A2 (en) * 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2003070173A2 (en) * 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1482957A4 (en) * 2002-02-15 2006-07-19 Merckle Gmbh ANTIBIOTIC CONJUGATES
RS20050006A (en) * 2002-07-08 2007-09-21 Glaxo Smith Kline Istraživački Centar Zagreb D.O.O., Novel compounds,compositions as carriers for steroid/non- steroid anti-inflammatory,antineoplastic and antiviral active molecules
RU2330858C2 (ru) * 2002-07-08 2008-08-10 Глаксомитклайн Истраживацки Центар Загреб Д.О.О. Новые соединения, составы и способы лечения воспалительных заболеваний и состояний
JP2005536488A (ja) * 2002-07-08 2005-12-02 プリヴァ−イストラジヴァキ・インスティトゥ・ディー・オー・オー 新規な非ステロイド抗炎症物質、組成物、およびその使用方法
HRP20030324A2 (en) * 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect

Also Published As

Publication number Publication date
US20060035845A1 (en) 2006-02-16
AU2005273592A1 (en) 2006-02-23
IL181240A0 (en) 2007-07-04
KR20070046917A (ko) 2007-05-03
WO2006018698A2 (en) 2006-02-23
CA2576291A1 (en) 2006-02-23
MX2007001669A (es) 2007-04-10
MA28809B1 (fr) 2007-08-01
EP1778292A2 (en) 2007-05-02
BRPI0514254A (pt) 2008-06-03
WO2006018698A3 (en) 2006-12-28
JP2008509899A (ja) 2008-04-03
RU2007108544A (ru) 2008-09-20

Similar Documents

Publication Publication Date Title
NO20071244L (no) Anvendelse av cellespesifikke konjugater for behandling av inflammasjonssykdommer i gastrointestinaltrakten
CY1121350T1 (el) Απο του στοματος φαρμακοτεχνικες μορφες αναλογων κυτιδινης και μεθοδοι χρησης αυτων
RU2013111077A (ru) Дипептидное пролекарство, его применение и лекарственное средство
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
WO2007096151A3 (en) Inhibitors of p38-kinase for treatment of pulmonary hypertension
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
ATE524450T1 (de) 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren
NO20050571L (no) Nye ikke steroide anti-inflammatoriske substanser, sammensetninger og metoder for deres anvendelse
NO20065787L (no) Kombinasjoner av glykopyrrolat og beta2 adrenoreseptoragonster
WO2007127635A3 (en) Diketo-piperazine and piperidine derivatives as antiviral agents
EA200970088A1 (ru) Модуляторы метаболизма и лечение связанных с ним нарушений
JP2008201787A5 (no)
MY139577A (en) Anti-inflammatory androstane derivative
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
NO20084328L (no) Nye forbindelser
ATE479433T1 (de) Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
JP2009517411A5 (no)
MX2010004232A (es) Compuesto de indolina de pirimidilo.
NO20052730L (no) Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
MA33463B1 (fr) Compositions à dose pharmaceutique solide fixe comprenant de l'irbésartan et de l'amlodipine, leur préparation et leur application thérapeutique
ECSP10010052A (es) Formulaciones galenicas de alisquireno y valsartan
MX2007005073A (es) Conjugados con actividad antiinflamtoria.
WO2006050472A3 (en) Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
WO2006050471A3 (en) Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application